benzothiophene compound

LY88074 analog 1, a benzothiophene compound with nitrogen-containing non-basic side chains, can be utilized either independently or alongside estrogen or progestin. This agent is effective for mitigating post-menopausal symptoms, including osteoporosis, cardiovascular-related pathological conditions, and estrogen-dependent cancer.

DB-381831 is an organic phosphorus compound with a complex molecular structure that includes a benzothiophene ring, carboxyl group, diethoxyphosphoryl group, and difluoromethyl group. It may be used as an important intermediate or reagent in organic synthesis reactions. DB-381831 is involved in the synthesis of AK-2292, a STAT5 (Signal transducer and activator of transcription 5) small molecule degradator.

JSF-2827 is a benzothiophene compound that exhibits antibacterial activity against Enterococcus faecium.

Raloxifene-d4 (hydrochloride) is the deuterated form of Raloxifene. Raloxifene (Keoxifene) is a selective estrogen receptor modulator (SERM) of the benzothiophene class. It exhibits estrogen agonistic effects on bone and blood lipids, while acting as an estrogen antagonist on breast and uterine tissues. This compound is utilized in research related to breast cancer and osteoporosis.